Bronchopulmonary Dysplasia and Risk of Developmental Delay: An EPIPAGE-2 Cohort Study - Université Paris Cité Accéder directement au contenu
Article Dans Une Revue Neonatology Année : 2022

Bronchopulmonary Dysplasia and Risk of Developmental Delay: An EPIPAGE-2 Cohort Study

Résumé

Background: Overall and respiratory management of preterm children are constantly evolving, which might have changed both the pathophysiology and neurodevelopmental consequences of bronchopulmonary dysplasia (BPD). Objectives: The objective of this study is to determine whether the previously shown association between BPD and risk of developmental delay persists. Methods: The study population was children born before 32 weeks’ gestation from the French prospective cohort EPIPAGE-2. The exposure was BPD assessed at 36 weeks’ postmenstrual age. The main outcome was risk of developmental delay defined by an Age & Stages Questionnaires (ASQ) score below threshold at 24 months’ corrected age. Results: The analyzed population included 2,706 children. Among those with available ASQ score, 196/1,587 had BPD and 671/1,587 had an ASQ score below threshold. BPD was associated with an ASQ score below threshold (odds ratio 1.52, 95% confidence interval 1.11–2.08; p = 0.008). Conclusions: BPD was strongly associated with risk of developmental delay.
Fichier non déposé

Dates et versions

hal-04012908 , version 1 (03-03-2023)

Identifiants

Citer

Ludovic Tréluyer, Pierre-Henri Jarreau, Laetitia Marchand-Martin, Valerie Benhammou, Alexandra Nuytten, et al.. Bronchopulmonary Dysplasia and Risk of Developmental Delay: An EPIPAGE-2 Cohort Study. Neonatology, 2022, 119 (1), pp.124-128. ⟨10.1159/000520451⟩. ⟨hal-04012908⟩
22 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More